Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Preface

Takeo Fukushima
Anticancer Research August 2021, 41 (8) 4045; DOI: https://doi.org/10.21873/anticanres.41.8.4045
Takeo Fukushima
President of the Society of Biotherapeutic Approaches (SBA)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

This special issue of ANTICANCER RESEARCH presents the Proceedings of the 24th Annual Meeting of the Society of Biotherapeutic Approaches. It is our great pleasure to introduce this issue expressing my sincere gratitude to the Editors of Anticancer Research for kindly accepting and publishing the proceedings of our regional meeting in Japan in ANTICANCER RESEARCH.

The 24th meeting was held in Fukuoka, Japan on December 5, 2020, chaired by Professor Shingo Miyamoto, Department of Obstetrics and Gynecology, Faculty of Medicine, Fukuoka University, Japan and Director, Takashi Morisaki, Fukuoka General Cancer Clinic, Fukuoka, Japan.

This year’s special lectures were given by Director, Yusuke Nakamura, Cancer Precision Medicine Center of Japanese Foundation for Cancer Research, Tokyo, Japan, Kazuma Kiyotani, Director Researcher of the Cancer Precision Medicine Center of Japanese Foundation for Cancer Research, Tokyo, Japan, and Director, Takashi Morisaki, Director of the Fukuoka General Cancer Clinic, Fukuoka, Japan, on the theme of “Cancer Immuno-Cell Therapy Targeting Neoantigens”. In addition, there were many oral presentations on a wide range of basic and clinical topics, offering impressive advances in this field.

The main aims of our Society are to facilitate good communication between basic researchers and clinicians, and to perform clinical trials with adequate informed consent in an appropriate and professional manner. These aspects include important issues for the progress of biotherapy as well as for medicine in general. It is our sincere hope that these Proceedings will contribute to further progress in the field of biotherapy and that our members will continue to foster the aims of our Society.

  • Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
PreviousNext
Back to top

In this issue

Anticancer Research: 41 (8)
Anticancer Research
Vol. 41, Issue 8
August 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preface
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
15 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Preface
Takeo Fukushima
Anticancer Research Aug 2021, 41 (8) 4045; DOI: 10.21873/anticanres.41.8.4045

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Preface
Takeo Fukushima
Anticancer Research Aug 2021, 41 (8) 4045; DOI: 10.21873/anticanres.41.8.4045
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Predictive and Prognostic Value of SUOX Expression in Pancreatic Ductal Adenocarcinoma
  • Liberal Application of Portal Vein Embolization for Right Hepatectomy Against Hepatocellular Carcinoma: Strategy to Achieve Zero Mortality for a Damaged Liver
  • Pancreaticoenterostomy With Seromuscular-parenchymal Anastomosis for Prevention of Postoperative Pancreatic Fistula in Distal Pancreatectomy
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2022 Anticancer Research

Powered by HighWire